chevron_leftBack
As of 17 June 2026, CKD Bio Corp. has a market cap of $71.35M USD, ranking #28043 globally and #1469 in South Korea.
It ranks #2529 in the Healthcare sector, and #907 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$71.35MUSD
107.69B KRW
Revenue (TTM)
$105.96MUSD
159.93B KRW
EBITDA (TTM)
-$4.9MUSD
-7.4B KRW
Net Income (TTM)
-$15.32MUSD
-23.13B KRW
EBITDA Margin
-4.6%
Profit Margin
-14%
PS Ratio
0.7
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Wan-Kap Park
open_in_new
Employees
519
Founded
1941
Website
ckdbio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.6% | -0.6% | 1.1% | -9.7% | -10% | -14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
063160
(주)종근당바이오
ISIN: KR7063160006
Shares Out.:
Shares Outstanding:
5.486M1
Shares Float:
3.338M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
19,510 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CKD Bio Corp.
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.22B
13K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.83B
9K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.28B
7K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$5.0B
7K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.58B
6K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.48B
6K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
767K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
505K%
|
97.4
|
|
SIX: RO
|
$323.08B
453K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.5B
406K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.99B
387K%
218.9B CHF
|
20.5
|
chevron_leftBack